Work

Commentary: Neoadjuvant checkpoint inhibitors in resectable non–small cell lung cancer—Ready for prime time?

Year: 2019

Type: editorial

Source: Journal of Thoracic and Cardiovascular Surgery

DOI: 10.1016/j.jtcvs.2019.09.042

Authors: Boris Sepesi, Tina Cascone

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Boehringer Ingelheim, Society for Immunotherapy of Cancer, MedImmune, University of Texas MD Anderson Cancer Center

OpenAlex ID: W2976710043

Cites: 11

Cited by: 2

Related to: 10